Cargando…
COVID-19 associated mucormycosis (CAM) in India: a formidable challenge
Together with the ongoing serious COVID-19 second wave in India, a serious fungal infection, mucormycosis has been increasingly found in COVID-19-recovered patients. Colloquially known as ‘black fungus’, mucormycosis commonly causes necrosis in the head and neck including the nose, paranasal sinuses...
Autores principales: | Rao, Vishal U.S., Arakeri, Gururaj, Madikeri, Gaurav, Shah, Ashwin, Oeppen, Rachel S., Brennan, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239211/ https://www.ncbi.nlm.nih.gov/pubmed/34507870 http://dx.doi.org/10.1016/j.bjoms.2021.06.013 |
Ejemplares similares
-
Pathogenesis of COVID-19-associated mucormycosis (CAM) in India: probing the triggering factors
por: Arakeri, Gururaj, et al.
Publicado: (2022) -
COVID-associated mucormycosis (CAM): is the Delta variant a cause?
por: Arakeri, Gururaj, et al.
Publicado: (2022) -
Does Yadgir population have copper-mediated intrinsic immunity to resist COVID-19 challenge?
por: Patil, Shekar, et al.
Publicado: (2021) -
Methylene blue as an anti-COVID-19 mouthwash in dental practice
por: Arakeri, Gururaj, et al.
Publicado: (2021) -
COVID-19: Loss of bridging between innate and adaptive immunity?
por: Rao, Vishal U.S, et al.
Publicado: (2020)